Literature DB >> 5090420

Inhibition of Walker 256 intramuscular carcinoma in rats by administration of hydrazine sulfate.

J Gold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5090420     DOI： 10.1159/000224555

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  4 in total

Review 1.  Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-19       Impact factor: 8.262

2.  Preparation, characterization of 2-deoxy-D-glucose functionalized dimercaptosuccinic acid-coated maghemite nanoparticles for targeting tumor cells.

Authors:  Fei Xiong; Zi-yi Zhu; Chen Xiong; Xiao-qing Hua; Xiu-hong Shan; Yu Zhang; Ning Gu
Journal:  Pharm Res       Date:  2011-12-16       Impact factor: 4.200

3.  Clinical study of hydrazine sulfate in advanced cancer patients.

Authors:  E Spremulli; G L Wampler; W Regelson
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats.

Authors:  K C Fearon; M J Tisdale; T Preston; J A Plumb; K C Calman
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.